Sign In

Delhi News Daily

  • Home
  • Fashion
  • Business
  • World News
  • Technology
  • Sports
  • Politics
  • Lifestyle
  • Entertainment
Reading: IPO Calendar: 2 issues to keep investors busy but mainboard activity remains muted – Delhi News Daily
Share

Delhi News Daily

Font ResizerAa
Search
Have an existing account? Sign In
Follow US
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Delhi News Daily > Blog > Business > IPO Calendar: 2 issues to keep investors busy but mainboard activity remains muted – Delhi News Daily
Business

IPO Calendar: 2 issues to keep investors busy but mainboard activity remains muted – Delhi News Daily

delhinewsdaily
Last updated: May 9, 2026 5:12 am
delhinewsdaily
Share
SHARE


India’s primary market will stay busy next week with two SME public issues collectively looking to raise nearly Rs 47 crore, offering investors exposure to sectors ranging from flexible packaging to pharma. Both IPOs, RFBL Flexi Pack and Goldline Pharmaceutical, will open for subscription on May 12 and close on May 14, with tentative listings scheduled for May 19.

The larger of the two issues is RFBL Flexi Pack, which aims to raise Rs 35.33 crore through an entirely fresh issue of 70.65 lakh shares. The company has fixed a price band of Rs 47-50 per share. At the upper band, retail investors will need to invest Rs 3 lakh, as the minimum application size is 6,000 shares. RFBL will list on the NSE SME platform. Currently, the GMP for the IPO is zero.

Incorporated in 2005, RFBL manufactures and trades printed multilayer flexible packaging materials, including plastic film rolls and pouches used by clients in food, pharmaceuticals and home care segments. The Gujarat-based company follows a B2B model and offers customised packaging solutions using materials such as BOPP, CPP and laminated films.

On the financial front, RFBL reported total income of Rs 135.46 crore in FY25, compared with Rs 79.96 crore in FY24, while profit after tax rose to Rs 8.33 crore from Rs 5.79 crore a year earlier.

The company plans to use IPO proceeds for capital expenditure, working capital needs and general corporate purposes.

ET logo

Live Events


The second issue, Goldline Pharmaceutical, is looking to raise Rs 11.61 crore through a fresh issue of 27 lakh shares. The company has fixed a price band of Rs 41-43 per share, with a minimum retail investment of Rs 2.58 lakh for 6,000 shares. Goldline will list on the BSE SME platform.

Goldline operates an asset-light pharmaceutical marketing business, selling medicines under its “Goldline” brand across segments including cardiology, orthopaedics, paediatrics, diabetes care and critical care. Rather than manufacturing products in-house, the company partners with third-party manufacturers, allowing it to scale distribution with lower fixed costs.Its products are sold across states including Maharashtra, Madhya Pradesh, Odisha, Jharkhand, Tamil Nadu, Rajasthan and Bihar.

Financially, Goldline reported FY25 revenue of Rs 28.06 crore, up from Rs 23.57 crore in FY24, while profit after tax rose to Rs 2.83 crore from Rs 1.81 crore.

The company plans to utilise most of the IPO proceeds toward repayment of borrowings worth Rs 8.35 crore.



Source link

Share This Article
Twitter Email Copy Link Print
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article विदेश भागने की तैयारी, रंगदारी और सट्टे का कारोबार, कौन है दिल्ली का गैंगस्टर रोहित चौधरी जो हुआ गिरफ्तार – Delhi News Daily
Next Article More hunting, fewer limits: Trump lifts restrictions in national parks and wilderness areas – The Times of India – Delhi News Daily
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Jefferies cuts KEI Industries target price by 11%. Will UltraTech’s entry put the company at risk? – Delhi News Daily
  • Pranay Reddy Vanga takes a dig at reviewers over ‘Romanchakam’ reviews, challenges them to review Prabhas and Triptii Dimri starrer: ‘Let’s see when Spirit releases’ – Delhi News Daily
  • Why You May Not Be Able to Watch India-Afghanistan T20I in Delhi? Here’s Everything You Need to Know – Delhi News Daily
  • BRICS & Critical Partnerships: Can The Bloc Reshape The Global Order? | Vinay Sahasrabuddhe – Delhi News Daily
  • Decathlon India’s B2B business grows 20-fold in five years, now contributes 10 per cent of overall business – Delhi News Daily

Recent Comments

No comments to show.

You Might Also Like

Business Standard
Business

Berkshire shareholders gather for Greg Abel’s first annual meeting – Delhi News Daily

Greg Abel will preside over his first Berkshire Hathaway annual meeting on Saturday, where shareholders hope to learn how…

7 Min Read
Business

Trent announces first-ever bonus issue in 1:2 ratio. Check details – Delhi News Daily

Trent, the parent company of retail chains Westside and Zudio, on Wednesday declared its first-ever bonus issue, offering shares in…

4 Min Read
Business Standard
Business

Nalco Q4 FY26 results: Net profit falls 16.6% to ₹1,722 cr, revenue dips – Delhi News Daily

State-run Nalco on Thursday reported a 16.6 per cent drop in consolidated net profit to ₹1,722.44 crore for the…

2 Min Read
Business

Global Market Today: Asian stocks recover as chips rebound, oil dips – Delhi News Daily

Asian equities advanced after three days of losses as a selloff in chip stocks eased ahead of megacap tech earnings…

4 Min Read

Delhi News Daily

© Delhi News Daily Network.

Incognito Web Technologies

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?